UK biotechs struggling to access finance as scale-up concerns grow - Pharmaceutical Technology

The UK Government has prioritised life science sector growth, but industry members have called for more funding. The UK Government has prioritised life science sector growth, but industry members have called for more funding. The pharmaceutical industry is critical to the UK Government’s long-term plans to boost the life science sector, contributing £17.6bn in direct gross value added (GVA) annually to the economy. Credit: Mehaniq/Shutterstock.com. Lacklustre routes to capital mean UK biotechs are struggling to grow as fast as international rivals, according to the British BioIndustry Association (BIA). In an industry roundtable with representatives from British biotechs, access to finance…

Source: Pharmaceutical Technology